A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol Russo, Ethan, et al.
Medical Hypothesis. 2006, 66: 234-246.

Endocannabinoid mechanisms of pain modulation. Hohmann, Andrea G, et al.
The AAPS Journal. 2006 8(4): E693-E708.

A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis (cannador) for postoperative pain management. Holdcroft, Antita, et al.
Anesthesiology. 2006, 104(5): 1040-1046 (abstract).

Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. Hazekamp, Arno, et al.
Journal of Pharmaceutical Sciences. 2006, 95(6): 1308-1317 (abstract).

Interaction between terpenes and penicillin on bacterial strains resistant to beta-lactam antibiotics. Gallucci, N, et al.
Molecular Medicinal Chemistry. 2006, 10: 30-32.

History of cannabis as a medicine: a review. Zuardi, Antonio Waldo
Revista Brasileira de Psiquiatria. 2006, 28(2): 153-157.

Cannabidiol, a cannabis sativa constituent, as an antipsychotic drug. Zuardi, A W, et al.
Brazilian Journal of Medical and Biological Research. 2006, 39(4): 421-429.

Delta-9 tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production. Shmist, Y A, et al.
Molecular Cell Biochemistry. 2006 Feb. (abstract).

Antitumor activity of plant cannabinoids emphasis on the effect of cannabidiol on human breast carcinoma. Ligresti, Alessia, et al.
The Journal of Pharmacology and Experimental Therapeutics. 2006 318(3): 1375-1387.

Endocannabinoid mechanisms of pain modulation. Hohmann, Andrea G, et al.
The AAPS Journal. 2006 Nov. 17 8(4): E693-708.

ENTER YOUR EMAIL AND GET

10% OFF

YOUR NEXT ORDER

Be the first to learn about our new product additions, events and special promotions.